by CCHR National Affairs Office | Feb 16, 2023
Even the FDA does not always get all relevant clinical trials before approving drugs, according to published reports. Doctors rely on the evidence in peer-reviewed clinical trials for accurate assessment of the safety and efficacy of drugs, but this requires that the...
by CCHR National Affairs Office | Feb 3, 2023
The new national suicide prevention hotline, “988,” due to begin service in July, was intended to be an easy-to-remember number aimed at getting depressed individuals nationwide to call anonymously and confidentially to get emotional support by phone. Instead, the...
by CCHR National Affairs Office | Feb 2, 2023
Warrior-mindset training conditions law enforcement officers to fear the people they serve, putting Blacks at greater risk of deadly force, critics say. The brutal and ultimately fatal beating of Tyre Nichols by Memphis police officers has again ignited national...
by CCHR National Affairs Office | Jan 19, 2023
Other research also found that psychiatric hospitalization – and even psychiatric treatment without hospitalization – is linked to increased risk of suicide. A recent study of teens and young adults who were admitted to psychiatric hospitals for treatment found that...
by CCHR National Affairs Office | Jan 11, 2023
A common antidepressant medication has no clinically relevant benefit for depressed children and teens, but carries safety risks, researchers claim. A reexamination of the data originally submitted to drug regulatory agencies to get approval for use of the...
